Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Coherus Bio
(NQ:
CHRS
)
4.050
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
600
Open
4.050
Bid (Size)
3.960 (1)
Ask (Size)
4.010 (7)
Prev. Close
4.050
Today's Range
4.050 - 4.050
52wk Range
3.655 - 10.99
Shares Outstanding
94,468,493
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
FDA Strikes Off Coherus BioSciences' New Injector Biosimilar Treatment For Cancer Patients
September 25, 2023
The FDA issued a Complete Response Letter regarding the Biologics License Application supplement for Udenyca Onbody, Coherus BioSciences Inc's (NASDAQ: CHRS) on-body injector (OBI) presentation of...
Via
Benzinga
Exposures
Product Safety
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 25, 2023
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
Via
Benzinga
Performance
YTD
-52.41%
-52.41%
1 Month
-19.80%
-19.80%
3 Month
+6.30%
+6.30%
6 Month
-32.50%
-32.50%
1 Year
-55.05%
-55.05%
More News
Read More
FDA Issues Complete Response Letter (CRL) for UDENYCA® ONBODY™ Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-Party Filler; Coherus Also Announces Completion of Toripalimab FDA Inspections
September 25, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Why Coherus BioSciences Stock Popped Today
August 03, 2023
Via
The Motley Fool
Coherus BioSciences Announces New Employment Inducement Grants
September 22, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus Completes Surface Oncology Acquisition
September 08, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Why Coherus BioSciences Stock Was Plunging This Week
September 08, 2023
Via
The Motley Fool
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
September 02, 2023
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Analyst Ratings for Coherus BioSciences
August 03, 2023
Via
Benzinga
Coherus BioSciences to Participate at Upcoming September Investor Conferences
September 01, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
August 31, 2023
From
Surface Oncology, Inc.
Via
GlobeNewswire
Coherus BioSciences Announces New Employment Inducement Grants
August 22, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Earnings Preview For Coherus BioSciences
August 01, 2023
Via
Benzinga
10 Analysts Have This to Say About Coherus BioSciences
July 14, 2023
Via
Benzinga
Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 03, 2023
Via
Benzinga
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
August 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 02, 2023
Via
Benzinga
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
August 02, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus BioSciences to Report Second Quarter 2023 Financial Results on August 02, 2023
July 26, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
July 24, 2023
Via
Benzinga
Coherus BioSciences Announces New Employment Inducement Grants
July 21, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors
July 20, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Mark Cuban's Pharmacy Company Lands Deal With Top 10 US Retailer: Here Are The Details
July 19, 2023
Via
Benzinga
Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
July 13, 2023
From
Coherus BioSciences, Inc.
Via
GlobeNewswire
Cramer Is Still Bullish On AI Company Up 155% YTD: 'I Remain A Buyer'
July 11, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.